Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines

Patent 8883805 was granted and assigned to Boehringer Ingelheim on November, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88838050

Patent Inventor Names

Adil Duran0

Thomas Nicola0

Thorsten Pachur0

Waldemar Pfrengle0

Date of Patent

November 11, 2014

Patent Application Number

137821490

Date Filed

March 1, 2013

Patent Citations Received

‌

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

‌

US Patent 11919903 Polymorphs

‌

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

Patent Primary Examiner

‌

Kamal Saeed

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8883805 Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API